Skip to main content
Fig. 2 | BMC Medical Genomics

Fig. 2

From: Six years’ experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias

Fig. 2

Overview of the patient and DNA sample journeys. Upon arrival to clinic (Visit 1), the patient undergoes a clinical assessment (left branch). During their clinic visit, blood is drawn for subsequent lipid tests, as well as genetic assessment (right branch). After DNA has been extracted and has undergone sequencing and bioinformatic processing, genetic factors that are relevant to the patient’s phenotype or present as risk factors for future health concerns are relayed back to the patient at a follow-up appointment. During the follow-up appointment (Visit 2), an additional clinical assessment is performed if required. Advice is given by combined clinical parameter with genetic results, if appropriate

Back to article page